Influenza Vaccine - Statewide - MMCAP

The State of Missouri, through the Minnesota Multistate Contracting Alliance for Pharmacy (MMCAP) cooperative purchasing program, is soliciting bids for a statewide influenza vaccine contract. The procurement, identified by solicitation number CPPC30034901801655, is open to all vendors and seeks to establish a contract for flu vaccine delivery to various locations throughout Missouri. The solicitation was released on August 28, 2018, with responses due by August 29, 2018, at 8:00 PM GMT. The contract period will run from the date of award through December 31, 2022, with delivery terms specified as Free On Board (FOB) Destination. Vendors must submit their responses either electronically through the MissouriBUYS system or as a hard copy to the Division of Purchasing. The primary point of contact for this solicitation is Tammy Michel from the Missouri Division of Purchasing, who can be reached at 573-751-3114 or Tammy.Michel@oa.mo.gov. Payment terms for the contract are set at Net 45 days, and the solicitation includes a single line item for flu vaccine sold by lot, though specific quantities are not detailed in the documents.

The solicitation does not specify any set-aside designations or restrictions on the types of organizations that can respond, indicating it is open to all qualified vendors. No information is provided about incumbent vendors or current contractors, nor are there details about existing infrastructure or technology requiring integration. The total estimated contract value is not disclosed in any of the documents. The solicitation appears to be a commodity-based contract with flexibility for vendors to supply influenza vaccines to meet the state's needs during the contract period. The lack of specific quantity requirements suggests the state will purchase vaccines as needed throughout the contract term. There are no mentioned evaluation criteria beyond the standard submission requirements, and the documents do not outline any specific qualifications beyond the ability to provide influenza vaccines through the MMCAP cooperative purchasing program.